Skip to main content
. 2016 Jul 13;7(32):51713–51719. doi: 10.18632/oncotarget.10563

Figure 2. Knockdown efficiency of TUG1-specific siRNA in CRC cells.

Figure 2

(A) qRT-PCR showing the expression of TUG1 mRNA in LoVo/si cells was significantly decreased compared with control cells (**P < 0.01); (B) qRT-PCR showing the expression of TUG1 mRNA in SW480/si cells was significantly decreased compared with control cells (**P < 0.01); (C) MTT assay showing TUG1 knock down inhibited cell proliferation of LoVo cells; (D) S TUG1 knock down inhibited cell proliferation of SW480 cells.

HHS Vulnerability Disclosure